{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:15:42Z","timestamp":1762640142364},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,7]]},"DOI":"10.7759\/cureus.33478","type":"journal-article","created":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T11:27:13Z","timestamp":1673090833000},"source":"Crossref","is-referenced-by-count":1,"title":["Biologically Equivalent Dose Comparison Between Magnetic Resonance-Guided Adaptive and Computed Tomography-Guided Internal Target Volume-Based Stereotactic Body Radiotherapy for Liver Tumors"],"prefix":"10.7759","author":[{"given":"Kiyoshi","family":"Yoda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeru","family":"Arato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Starbuck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(00)81503-0","article-title":"MRI guided radiotherapy: an MRI based linear accelerator","volume":"56","author":"Lagendijk JJW","year":"2000","unstructured":"Lagendijk JJW, Bakker CJG. MRI guided radiotherapy: an MRI based linear accelerator. Radiot and Oncol. 2000, 56:S60-1. 10.1016\/S0167-8140(00)81503-0","journal-title":"Radiot and Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2007.10.034","article-title":"MRI\/linac integration","volume":"86","author":"Lagendijk JJ","year":"2008","unstructured":"Lagendijk JJ, Raaymakers BW, Raaijmakers AJ, et al.. MRI\/linac integration. Radiother Oncol. 2008, 86:25-9. 10.1016\/j.radonc.2007.10.034","journal-title":"Radiother Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2014.02.009","article-title":"The magnetic resonance imaging-linac system","volume":"24","author":"Lagendijk JJ","year":"2014","unstructured":"Lagendijk JJ, Raaymakers BW, van Vulpen M. The magnetic resonance imaging-linac system. Semin Radiat Oncol. 2014, 24:207-9. 10.1016\/j.semradonc.2014.02.009","journal-title":"Semin Radiat Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12516","article-title":"The development of the MRI linac system for online MRI-guided radiotherapy: a clinical update","volume":"280","author":"Lagendijk JJ","year":"2016","unstructured":"Lagendijk JJ, van Vulpen M, Raaymakers BW. The development of the MRI linac system for online MRI-guided radiotherapy: a clinical update. J Intern Med. 2016, 280:203-8. 10.1111\/joim.12516","journal-title":"J Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/aa9517","article-title":"First patients treated with a 1.5 T MRI-Linac: clinical proof of concept of a high-precision, high-field MRI guided radiotherapy treatment","volume":"62","author":"Raaymakers BW","year":"2017","unstructured":"Raaymakers BW, J\u00fcrgenliemk-Schulz IM, Bol GH, et al.. First patients treated with a 1.5 T MRI-Linac: clinical proof of concept of a high-precision, high-field MRI guided radiotherapy treatment. Phys Med Biol. 2017, 62:L41-50. 10.1088\/1361-6560\/aa9517","journal-title":"Phys Med Biol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-022-02033-2","article-title":"MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial","volume":"17","author":"Hoegen P","year":"2022","unstructured":"Hoegen P, Zhang KS, Tonndorf-Martini E, et al.. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial. Radiat Oncol. 2022, 17:59. 10.1186\/s13014-022-02033-2","journal-title":"Radiat Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e318074de34","article-title":"Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study","volume":"2","author":"Onishi H","year":"2007","unstructured":"Onishi H, Shirato H, Nagata Y, et al.. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol. 2007, 2:S94-100. 10.1097\/JTO.0b013e318074de34","journal-title":"J Thorac Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6063-9","article-title":"Biologically effective dose (BED) of stereotactic body radiation therapy (SBRT) was an important factor of therapeutic efficacy in patients with hepatocellular carcinoma (\u22645\u2009cm)","volume":"19","author":"Sun J","year":"2019","unstructured":"Sun J, Zhang T, Wang J, et al.. Biologically effective dose (BED) of stereotactic body radiation therapy (SBRT) was an important factor of therapeutic efficacy in patients with hepatocellular carcinoma (\u22645\u2009cm). BMC Cancer. 2019, 19:846. 10.1186\/s12885-019-6063-9","journal-title":"BMC Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-021-01778-6","article-title":"Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study","volume":"16","author":"Su TS","year":"2021","unstructured":"Su TS, Liu QH, Zhu XF, et al.. Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study. Radiat Oncol. 2021, 16:79. 10.1186\/s13014-021-01778-6","journal-title":"Radiat Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2020.09.038","article-title":"Dose-response relationship in stereotactic body radiation therapy for hepatocellular carcinoma: a pooled analysis of an Asian liver radiation therapy group study","volume":"109","author":"Kim N","year":"2021","unstructured":"Kim N, Cheng J, Huang WY, et al.. Dose-response relationship in stereotactic body radiation therapy for hepatocellular carcinoma: a pooled analysis of an Asian liver radiation therapy group study. Int J Radiat Oncol Biol Phys. 2021, 109:464-73. 10.1016\/j.ijrobp.2020.09.038","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2017.09.007","article-title":"UK consensus on normal tissue dose constraints for stereotactic radiotherapy","volume":"30","author":"Hanna GG","year":"2018","unstructured":"Hanna GG, Murray L, Patel R, et al.. UK consensus on normal tissue dose constraints for stereotactic radiotherapy. Clin Oncol (R Coll Radiol). 2018, 30:5-14. 10.1016\/j.clon.2017.09.007","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030716","article-title":"MRI-guided online adaptive stereotactic body radiation therapy of liver and pancreas tumors on an MR-Linac system","volume":"14","author":"Stanescu T","year":"2022","unstructured":"Stanescu T, Shessel A, Carpino-Rocca C, et al.. MRI-guided online adaptive stereotactic body radiation therapy of liver and pancreas tumors on an MR-Linac system. Cancers (Basel). 2022, 14:10.3390\/cancers14030716","journal-title":"Cancers (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1117\/1.JMI.7.4.042805","article-title":"Virtual clinical trials in medical imaging: a review","volume":"7","author":"Abadi E","year":"2020","unstructured":"Abadi E, Segars WP, Tsui BM, et al.. Virtual clinical trials in medical imaging: a review. J Med Imaging (Bellingham). 2020, 7:042805. 10.1117\/1.JMI.7.4.042805","journal-title":"J Med Imaging (Bellingham)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2017.12.288","article-title":"Local control after stereotactic body radiation therapy for liver tumors","volume":"110","author":"Ohri N","year":"2021","unstructured":"Ohri N, Tom\u00e9 WA, M\u00e9ndez Romero A, et al.. Local control after stereotactic body radiation therapy for liver tumors. Int J Radiat Oncol Biol Phys. 2021, 110:188-95. 10.1016\/j.ijrobp.2017.12.288","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1259\/0007-1285-62-740-679","article-title":"The linear-quadratic formula and progress in fractionated radiotherapy","volume":"62","author":"Fowler JF","year":"1989","unstructured":"Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 1989, 62:679-94. 10.1259\/0007-1285-62-740-679","journal-title":"Br J Radiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/130680-biologically-equivalent-dose-comparison-between-magnetic-resonance-guided-adaptive-and-computed-tomography-guided-internal-target-volume-based-stereotactic-body-radiotherapy-for-liver-tumors","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:52:27Z","timestamp":1707508347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/130680-biologically-equivalent-dose-comparison-between-magnetic-resonance-guided-adaptive-and-computed-tomography-guided-internal-target-volume-based-stereotactic-body-radiotherapy-for-liver-tumors"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,7]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.33478","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,7]]}}}